Dynamaxx Clinics SPV I LLC Pitch Deck Teardown: A $1M

Executive Summary and Investment Terms

Slide 1: Title Slide

The deck opens with the branding 'MAXXHEALTH Anti-Aging & Rejuvenation.' The visual features an older couple, signaling a target demographic of seniors or aging adults. The subtitle identifies this as an 'Investor Presentation.'

Slide 2: DynaMAXX Clinics SPV I, LLC Overview

This slide provides the core financial terms of the offering. The company is raising $1,000,000 through Class B Membership Interests with a $100,000 minimum investment . The terms include a 6% preferred annual return . A significant detail is the distribution waterfall: 80% of EBITDA will be paid to Class B members until all capital and the preferred return are paid back. After this point, Class B interests convert into a 20% stake in Class A Membership Interests. The slide also notes that 20% of the offering will be invested into the parent company, Full Alliance Group, Inc. (FAGI). The proceeds are earmarked to open four clinics in the Southeastern United States, with the first clinic already open in The Villages, FL.

Service Offerings and Market Opportunity

Slide 3: Maxx Health Clinics Services

This slide enumerates the clinical offerings, which include EBOO Therapy , IV Therapy , Shockwave Therapy , and PRP, Exosomes & Stem Cell treatments. It highlights a weight loss regimen using 'Viscetrim' capsules and injectables. Notably, it mentions that EBOO therapy costs $2,500 per treatment . The slide introduces the customer acquisition strategy: a DynaMAXX MLM model where members refer clients. It also mentions the sale of proprietary supplements and topicals at each location.

Slide 4: Why Invest? Opportunity

This slide frames the medical aesthetics industry as a 'Gigantic Size and Scale Potential' that has been 'Generally Left Alone by Private Equity.' It cites a 2022 Medical Spa State of the Industry Report by AmSpa, noting growth of greater than 20% each year since 2015 (excluding 2020). A quote from Dominic Mazzone, CEO of MSP, emphasizes that the sector is attractive because it is 'private pay, primarily, without insurance reimbursement,' making it 'recession-resilient.'

Unit Economics and Pro Forma Projections

Slide 5: Pro Forma Start Up Costs Per Location

The company estimates a build-out cost of $135,000 per location . This includes $27,000 for an EBOO Machine and $65,000 in working capital . To minimize these costs, the company explicitly states it will only lease properties previously used as medical facilities. This slide uses a background image of a beach, maintaining the lifestyle/wellness aesthetic of the brand.

Slide 6: Pro Forma Profit & Loss Per Location

This slide details the operational assumptions for a single clinic. It assumes 20 customers per day during the first year, operating on a five-day work week with 4 staff members . The revenue model relies on high-value patients: one PRP patient per day at $1,750 and one EBOO patient per day at $2,000 . All other services are averaged at $73.50 per customer. The visual shows the exterior signage of a Maxx Health facility.

Slide 7: Pro Forma Cash Flow for Investment

The company projects a payback of investment plus the 6% preferred return in the second year . The slide clarifies that this payback calculation does not include any potential returns from the 20% of capital diverted into the parent company (FAGI) Series F Preferred Stock. It claims that once the SPV is fully funded and revenue is stabilized, the estimated Return on Investment is 80+% in the first fiscal year , though it is unclear if this refers to the first year of full operation or the first year of the SPV's existence.

Slide 8: Investment Overview Table

This slide summarizes the terms previously mentioned in a tabular format. It reiterates the $1,000,000 cap , the $100,000 to $1,000,000 investment range , and the 20% diversion to FAGI . It confirms the distribution of 80% of EBITDA after the preferred return and the eventual conversion into a 20% equity stake in the SPV.

What Works in This Deck

Specific Unit Economics: The deck provides clear, granular estimates for build-out costs ($135,000) and specific equipment costs ($27,000 for EBOO machines). This allows investors to verify the feasibility of the $1M raise against the goal of opening four clinics. · Defined Investor Waterfall: The use of a 6% preferred return and an 80% EBITDA sweep until payback is a very specific, investor-friendly structure that clearly defines how and when capital is returned. · Targeted Geography: By focusing on The Villages, FL, and the Southeastern US, the company is targeting one of the highest-density retiree populations in the country, which aligns with their anti-aging service offering. · Operational Efficiency Strategy: The decision to only lease existing medical facilities to reduce CAPEX is a practical operational detail that shows a focus on capital efficiency.

What Is Missing From This Deck

Team Slide: The 8 slides provided contain no information regarding the management team, medical directors, or clinical staff. In a medical services business, the credentials of the practitioners are critical. · Competitive Analysis: There is no mention of other anti-aging clinics, medical spas, or wellness centers in the Southeastern US. The deck assumes a vacuum in the market. · Risk Factors: Given the mention of 'Stem Cell' and 'Exosomes' treatments, which are subject to evolving FDA regulations, the lack of a regulatory or risk disclosure slide is a significant omission. · Historical Performance: While the deck mentions the first clinic is open in The Villages, it provides no actual revenue or patient data from that location, relying entirely on 'pro forma' estimates. · MLM Details: The deck mentions a 'DynaMAXX MLM' model for customer acquisition but does not explain the cost of this channel or how it integrates with the clinical operations.

Founder Takeaways

Structure the deal for the stage: This deck is an excellent example of how to structure a 'rollout' investment. Instead of selling vague equity in a parent company, the founders created an SPV with a clear path to capital recovery (the 80% EBITDA sweep). This is often more attractive to private investors looking for yield and downside protection.

Be transparent about capital allocation: The deck is very clear that 20% of the money isn't going to the clinics, but to the parent company. While this might be a point of negotiation, stating it upfront in the terms prevents surprises during due diligence.

Focus on high-margin anchors: The revenue model isn't built on $73 facials; it's built on $2,000 EBOO treatments. By identifying the 'anchor' services that drive the majority of the margin, the founders make the path to profitability look much shorter.

Use 'Pro Forma' carefully: While pro formas are necessary for expansion decks, they should be balanced with actuals if a pilot location exists. If you have one clinic open, investors will expect to see how its actual performance compares to the projections for the next four.